We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PHIO Phio Pharmaceuticals Corporation

-0.01742 (-2.05%)
Feb 23 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 323,659
Bid Price 0.821
Ask Price 0.86
News -
Share Name Share Symbol Market Stock Type
Phio Pharmaceuticals Corporation PHIO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.01742 -2.05% 0.8325 23:00:01
Open Price Low Price High Price Close Price Previous Close
0.85 0.78 0.8587 0.825 0.849921
Trades Shares Traded VWAP Financial Volume Average Volume
678 323,659 US$ 0.8275429 US$ 267,842 -
Last Trade Type Quantity Price Currency
18:59:47 50 US$ 0.85 USD

Phio Pharmaceuticals Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2M 2.44M - 0 -11.48M -4.70 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Phio Pharmaceuticals News

Date Time Source News Article
2/20/202418:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/06/202409:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202407:00GlobeNewswire Inc.Phio Pharmaceuticals Announces Data Showing INTASYL May..
1/26/202416:00Edgar (US Regulatory)Form 8-K - Current report
12/28/202308:13Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
12/27/202323:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
12/19/202315:52Edgar (US Regulatory)Form S-1 - General form for registration of securities under..
12/08/202316:00Edgar (US Regulatory)Form 8-K - Current report
12/07/202307:00GlobeNewswire Inc.Phio Pharmaceuticals Announces Exercise of Warrants for $2.8..
11/09/202315:40Edgar (US Regulatory)Form 8-K - Current report
11/09/202315:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:30GlobeNewswire Inc.Phio Pharmaceuticals Reports Third Quarter 2023 Financial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No PHIO Message Board. Create One! See More Posts on PHIO Message Board See More Message Board Posts

Historical PHIO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Phio Pharmaceuticals Description

Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |